{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-012475","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2025-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.157051+00:00","generated_at":"2026-05-23T09:56:57.642332+00:00","sec_items":["1.02","1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Integrated BioPharma enters $4.5M PNC credit facility; replaces prior debt","bullets":["New $4M revolving line of credit and $500K convertible equipment line from PNC Bank (SOFR+250bps).","Maturity date April 5, 2026; borrowed funds for working capital and equipment purchases.","Prior credit facility fully repaid and terminated; payoff amount was $7,864.51 on April 15, 2025.","Reimbursement agreement covers standby/commercial letters of credit up to $1M sublimit."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-012475","json":"https://secwatch.observer/filing/0001437749-25-012475.json","markdown":"https://secwatch.observer/filing/0001437749-25-012475.md","text":"https://secwatch.observer/filing/0001437749-25-012475.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774925012475/0001437749-25-012475-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774925012475/inbp20250417c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T09:56:57.642332+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}